BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kavanagh ON, Albadarin AB, Croker DM, Healy AM, Walker GM. Maximising success in multidrug formulation development: A review. Journal of Controlled Release 2018;283:1-19. [DOI: 10.1016/j.jconrel.2018.05.024] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Serris I, Serris P, Frey KM, Cho H. Development of 3D-Printed Layered PLGA Films for Drug Delivery and Evaluation of Drug Release Behaviors. AAPS PharmSciTech 2020;21:256. [PMID: 32888114 DOI: 10.1208/s12249-020-01790-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
2 Fiore C, Baraghini A, Shemchuk O, Sambri V, Morotti M, Grepioni F, Braga D. Inhibition of the Antibiotic Activity of Cephalosporines by Co-Crystallization with Thymol. Crystal Growth & Design. [DOI: 10.1021/acs.cgd.1c01435] [Reference Citation Analysis]
3 Li S, Zhang F, Xiao X, Guo Y, Wen Z, Li M, Pu X. Prediction of Synergistic Drug Combinations for Prostate Cancer by Transcriptomic and Network Characteristics. Front Pharmacol 2021;12:634097. [PMID: 33986671 DOI: 10.3389/fphar.2021.634097] [Reference Citation Analysis]
4 Kavanagh ON, Walker G, Lusi M. Graph-Set Analysis Helps To Understand Charge Transfer in a Novel Ionic Cocrystal When the Δp Ka Rule Fails. Crystal Growth & Design 2019;19:5308-13. [DOI: 10.1021/acs.cgd.9b00770] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 3.7] [Reference Citation Analysis]
5 Menditto E, Orlando V, De Rosa G, Minghetti P, Musazzi UM, Cahir C, Kurczewska-Michalak M, Kardas P, Costa E, Sousa Lobo JM, Almeida IF. Patient Centric Pharmaceutical Drug Product Design-The Impact on Medication Adherence. Pharmaceutics 2020;12:E44. [PMID: 31947888 DOI: 10.3390/pharmaceutics12010044] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 9.5] [Reference Citation Analysis]
6 Kavanagh ON, Croker DM, Walker GM, Zaworotko MJ. Pharmaceutical cocrystals: from serendipity to design to application. Drug Discovery Today 2019;24:796-804. [DOI: 10.1016/j.drudis.2018.11.023] [Cited by in Crossref: 88] [Cited by in F6Publishing: 43] [Article Influence: 29.3] [Reference Citation Analysis]
7 Shi X, Zhou X, Shen S, Chen Q, Song S, Gu C, Wang C. Improved in vitro and in vivo properties of telmisartan in the co-amorphous system with hydrochlorothiazide: A potential drug-drug interaction mechanism prediction. Eur J Pharm Sci 2021;161:105773. [PMID: 33640500 DOI: 10.1016/j.ejps.2021.105773] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Maity DK, Paul RK, Desiraju GR. Drug-Drug Binary Solids of Nitrofurantoin and Trimethoprim: Crystal Engineering and Pharmaceutical Properties. Mol Pharm 2020;17:4435-42. [PMID: 32941048 DOI: 10.1021/acs.molpharmaceut.0c00090] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 3.5] [Reference Citation Analysis]
9 Kavanagh O, Elmes R, O'Sullivan F, Farragher J, Robinson S, Walker G. Investigating Structural Property Relationships to Enable Repurposing of Pharmaceuticals as Zinc Ionophores. Pharmaceutics 2021;13:2032. [PMID: 34959313 DOI: 10.3390/pharmaceutics13122032] [Reference Citation Analysis]
10 El Sayed M, Alhalaweh A, Bergström CAS. Impact of Simulated Intestinal Fluids on Dissolution, Solution Chemistry, and Membrane Transport of Amorphous Multidrug Formulations. Mol Pharm 2021;18:4079-89. [PMID: 34613730 DOI: 10.1021/acs.molpharmaceut.1c00480] [Reference Citation Analysis]
11 Wang L, Bu F, Li Y, Wu Z, Yan C. A Sulfathiazole–Amantadine Hydrochloride Cocrystal: The First Codrug Simultaneously Comprising Antiviral and Antibacterial Components. Crystal Growth & Design 2020;20:3236-46. [DOI: 10.1021/acs.cgd.0c00075] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
12 Abdelquader MM, Essa EA, El Maghraby GM. Inhibition of Co-Crystallization of Olmesartan Medoxomil and Hydrochlorothiazide for Enhanced Dissolution Rate in Their Fixed Dose Combination. AAPS PharmSciTech 2018;20:3. [PMID: 30560314 DOI: 10.1208/s12249-018-1207-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
13 Chew SL, Modica de Mohac L, Tolulope Raimi-Abraham B. 3D-Printed Solid Dispersion Drug Products. Pharmaceutics 2019;11:E672. [PMID: 31835682 DOI: 10.3390/pharmaceutics11120672] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
14 Robles-Martinez P, Xu X, Trenfield SJ, Awad A, Goyanes A, Telford R, Basit AW, Gaisford S. 3D Printing of a Multi-Layered Polypill Containing Six Drugs Using a Novel Stereolithographic Method. Pharmaceutics 2019;11:E274. [PMID: 31212649 DOI: 10.3390/pharmaceutics11060274] [Cited by in Crossref: 90] [Cited by in F6Publishing: 76] [Article Influence: 30.0] [Reference Citation Analysis]
15 El Sayed M, Alhalaweh A, Bergström CAS. Insights into Dissolution and Solution Chemistry of Multidrug Formulations of Antihypertensive Drugs. Mol Pharm 2020;17:4018-28. [PMID: 32870692 DOI: 10.1021/acs.molpharmaceut.0c00835] [Reference Citation Analysis]
16 Eleftheriadis GK, Genina N, Boetker J, Rantanen J. Modular design principle based on compartmental drug delivery systems. Adv Drug Deliv Rev 2021;178:113921. [PMID: 34390776 DOI: 10.1016/j.addr.2021.113921] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
17 Navrátil O, Kolář J, Zadražil A, Štěpánek F. Model-Based Evaluation of Drying Kinetics and Solvent Diffusion in Pharmaceutical Thin Film Coatings. Pharm Res 2022. [PMID: 35927510 DOI: 10.1007/s11095-022-03352-5] [Reference Citation Analysis]
18 Gao M, Deng H, Zhang W. Hyaluronan-based Multifunctional Nano-carriers for Combination Cancer Therapy. Curr Top Med Chem 2021;21:126-39. [PMID: 32962617 DOI: 10.2174/1568026620666200922113846] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Kavanagh ON, Wang C, Walker GM, Sun CC. Modulation of the powder properties of lamotrigine by crystal forms. Int J Pharm 2021;595:120274. [PMID: 33486026 DOI: 10.1016/j.ijpharm.2021.120274] [Reference Citation Analysis]